{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:46:38Z","timestamp":1788918398630,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      is the primary cause of hospitalized community-acquired pneumonia (CAP).\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      , though typically causing mild respiratory disease, can lead to pneumonia requiring hospitalization in adults. This study compared patients hospitalized with CAP caused by\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      or\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      aiming at increasing the understanding of when to sample for and empirically treat\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      From 2016 to 2018, 518 adults hospitalized with CAP were prospectively and consecutively enrolled. Medical history, symptoms, radiographic, and laboratory data were recorded. Naso- and oropharyngeal swabs were collected for PCR detection of\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      and other respiratory pathogens, while urine samples were analysed with two pneumococcal urinary antigens.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 32 patients with\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      and 126 patients with\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      were identified. Patients with\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      were significantly younger than those with pneumococcal CAP with a median age 39 versus 70 years.\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      accounted for only 6% of CAP cases across all ages, but for 33% of cases in patients\u2009&lt;\u200950 years.\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      patients had a longer duration of symptoms and were more often prescribed antibiotics prior to hospital admission. Neither symptoms nor chest imaging alone could distinguish between\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      and\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      . Although inflammatory markers such as CRP and leukocyte counts were significantly lower in\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      CAP, the median CRP value was still elevated at 178\u00a0mg\/L. Viral co-detection occurred in 14% of\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      patients, compared to 42% of those with\n                      <jats:italic>S. pneumoniae.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Symptoms and radiological findings could not distinguish between\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      and\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      . However, in hospitalized patients, particularly in younger individuals or those with antibiotic failure, liberal testing and treatment for\n                      <jats:italic>M. pneumoniae<\/jats:italic>\n                      is recommended.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-11811-8","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T10:25:41Z","timestamp":1760351141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics of Mycoplasma pneumoniae compared to Streptococcus pneumoniae in hospitalized adults with community-acquired pneumonia- a prospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Karin","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Wasserstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Ahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Riesbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"11811_CR1","doi-asserted-by":"crossref","unstructured":"Gadsby NJ, Musher DM. The microbial etiology of Community-Acquired pneumonia in adults: from classical bacteriology to host transcriptional signatures. Clin Microbiol Rev. 2022:e0001522.","DOI":"10.1128\/cmr.00015-22"},{"issue":"2","key":"11811_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/23744235.2020.1846776","volume":"53","author":"M Fally","year":"2021","unstructured":"Fally M, Israelsen S, Anh\u00f8j J, Benfield T, Tarp B, Kolte L, et al. The increasing importance of haemophilus influenzae in community-acquired pneumonia: results from a Danish cohort study. Infect Dis. 2021;53(2):122\u201330.","journal-title":"Infect Dis"},{"issue":"3","key":"11811_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s15010-021-01605-w","volume":"49","author":"DCW Braeken","year":"2021","unstructured":"Braeken DCW, Essig A, Panning M, Hoerster R, Nawrocki M, Dalhoff K, et al. Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade. Infection. 2021;49(3):533\u20137.","journal-title":"Infection"},{"issue":"6","key":"11811_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1370\/afm.1993","volume":"14","author":"C Marchello","year":"2016","unstructured":"Marchello C, Dale AP, Thai TN, Han DS, Ebell MH. Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: a meta-analysis. Ann Fam Med. 2016;14(6):552\u201366.","journal-title":"Ann Fam Med"},{"issue":"3","key":"11811_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-16","volume":"30","author":"KB Waites","year":"2017","unstructured":"Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017;30(3):747\u2013809.","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"11811_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.cmi.2016.05.028","volume":"22","author":"T Khoury","year":"2016","unstructured":"Khoury T, Sviri S, Rmeileh AA, Nubani A, Abutbul A, Hoss S, et al. Increased rates of intensive care unit admission in patients with Mycoplasma pneumoniae: a retrospective study. Clin Microbiol Infect. 2016;22(8):711\u20134.","journal-title":"Clin Microbiol Infect"},{"key":"11811_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12879-015-0803-5","volume":"15","author":"JC Holter","year":"2015","unstructured":"Holter JC, M\u00fcller F, Bj\u00f8rang O, Samdal HH, Marthinsen JB, Jenum PA, et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis. 2015;15:64.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"11811_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373(5):415\u201327.","journal-title":"N Engl J Med"},{"issue":"4","key":"11811_CR9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/thx.2010.143982","volume":"66","author":"C Cilloniz","year":"2011","unstructured":"Cilloniz C, Ewig S, Polverino E, Marcos MA, Esquinas C, Gabarrus A, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66(4):340\u20136.","journal-title":"Thorax"},{"issue":"4","key":"11811_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/23744235.2017.1399316","volume":"50","author":"S Athlin","year":"2018","unstructured":"Athlin S, Lidman C, Lundqvist A, Naucler P, Nilsson AC, Spindler C, et al. Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017. Infectious Diseases. 2018;50(4):247\u201372.","journal-title":"Infectious Diseases"},{"key":"11811_CR11","doi-asserted-by":"publisher","first-page":"1086648","DOI":"10.3389\/fpubh.2023.1086648","volume":"11","author":"K Hansen","year":"2023","unstructured":"Hansen K, R\u00fcnow E, Torisson G, Theilacker C, Palmborg A, Pan K, et al. Radiographically confirmed community-acquired pneumonia in hospitalized adults due to Pneumococcal vaccine serotypes in Sweden, 2016-2018-the ECAPS study. Front Public Health. 2023;11:1086648.","journal-title":"Front Public Health"},{"issue":"8","key":"11811_CR12","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1128\/CVI.00064-12","volume":"19","author":"MW Pride","year":"2012","unstructured":"Pride MW, Huijts SM, Wu K, Souza V, Passador S, Tinder C, et al. Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine. Clin Vaccine Immunol. 2012;19(8):1131\u201341.","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"11811_CR13","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1093\/cid\/ciaa158","volume":"71","author":"WV Kalina","year":"2020","unstructured":"Kalina WV, Souza V, Wu K, Giardina P, McKeen A, Jiang Q, et al. Qualification and clinical validation of an immunodiagnostic assay for detecting 11 additional Streptococcus pneumoniae Serotype-specific polysaccharides in human urine. Clin Infect Dis. 2020;71(9):e430\u20138.","journal-title":"Clin Infect Dis"},{"key":"11811_CR14","doi-asserted-by":"publisher","first-page":"1258981","DOI":"10.3389\/fpubh.2023.1258981","volume":"11","author":"K Hansen","year":"2023","unstructured":"Hansen K, Yamba Yamba L, Wasserstrom L, R\u00fcnow E, G\u00f6ransson T, Nilsson A, et al. Exploring the microbial landscape: uncovering the pathogens associated with community-acquired pneumonia in hospitalized patients. Front Public Health. 2023;11:1258981.","journal-title":"Front Public Health"},{"issue":"9","key":"11811_CR15","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1128\/JCM.00625-08","volume":"46","author":"S Kumar","year":"2008","unstructured":"Kumar S, Wang L, Fan J, Kraft A, Bose ME, Tiwari S, et al. Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J Clin Microbiol. 2008;46(9):3063\u201372.","journal-title":"J Clin Microbiol"},{"key":"11811_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00716-18","author":"N Sundell","year":"2019","unstructured":"Sundell N, Andersson LM, Brittain-Long R, Sundvall PD, Alsi\u00f6 \u00c5, Lindh M, et al. PCR detection of respiratory pathogens in asymptomatic and symptomatic adults. J Clin Microbiol. 2019. https:\/\/doi.org\/10.1128\/JCM.00716-18.","journal-title":"J Clin Microbiol"},{"issue":"35","key":"11811_CR17","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1016\/j.vaccine.2019.06.052","volume":"37","author":"C Valdarchi","year":"2019","unstructured":"Valdarchi C, Dorrucci M, Mancini F, Farchi F, Pimentel de Araujo F, Corongiu M, et al. Pneumococcal carriage among adults aged 50 years and older with co-morbidities attending medical practices in Rome, Italy. Vaccine. 2019;37(35):5096\u2013103.","journal-title":"Vaccine"},{"issue":"5734","key":"11811_CR18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1136\/bmj.4.5734.532","volume":"4","author":"PJ Neuvonen","year":"1970","unstructured":"Neuvonen PJ, Gothoni G, Hackman R, Bj\u00f6rksten K. Interference of iron with the absorption of tetracyclines in man. Br Med J. 1970;4(5734):532\u20134.","journal-title":"Br Med J"},{"key":"11811_CR19","unstructured":"he Norwegian Directorate of Health. National clinical guideline for use of antibiotics in hospital (in Norwegian) 2019. [Webpage]. Available from http:\/\/www.helsedirektoratet.no\/retningslinjer\/antibiotika-i-sykehus. Accessed 21 Feb 2025. [."},{"issue":"3","key":"11811_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3201\/eid2103.140927","volume":"21","author":"R Dumke","year":"2015","unstructured":"Dumke R, Schnee C, Pletz MW, Rupp J, Jacobs E, Sachse K, et al. Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011\u20132012. Emerg Infect Dis. 2015;21(3):426\u201334.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"11811_CR21","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s10096-021-04171-z","volume":"40","author":"R Mets\u00e4l\u00e4","year":"2021","unstructured":"Mets\u00e4l\u00e4 R, Ala-Korpi S, Rannikko J, Helminen M, Renko M. Mycoplasma pneumoniae may cause dyspnoea and hospitalisations in young healthy adults. Eur J Clin Microbiol Infect Dis. 2021;40(7):1427\u201331.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"11811_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae451","author":"K Hagman","year":"2024","unstructured":"Hagman K, Nilsson AC, Hedenstierna M, Ursing J. Outcomes of adjunctive corticosteroid treatment in hypoxemic adults hospitalized for Mycoplasma pneumoniae pneumonia: a retrospective cohort study. Clin Infect Dis. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae451.","journal-title":"Clin Infect Dis"},{"key":"11811_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00805-3","author":"A Gavaud","year":"2025","unstructured":"Gavaud A, Holub M, Asquier-Khati A, Faure K, Leautez-Nainville S, Le Moal G, et al. Mycoplasma pneumoniae infection in adult inpatients during the 2023-24 outbreak in France (MYCADO): a national, retrospective, observational study. Lancet Infect Dis. 2025. https:\/\/doi.org\/10.1016\/S1473-3099(24)00805-3.","journal-title":"Lancet Infect Dis"},{"key":"11811_CR24","doi-asserted-by":"crossref","unstructured":"Beeton ML, Zhang XS, Uldum SA, B\u00e9b\u00e9ar C, Dumke R, Gullsby K, et al. Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016. Euro Surveill. 2020;25(2).","DOI":"10.2807\/1560-7917.ES.2020.25.2.1900112"},{"issue":"8","key":"11811_CR25","first-page":"Cr387","volume":"14","author":"N Miyashita","year":"2008","unstructured":"Miyashita N, Ouchi K, Kawasaki K, Oda K, Kawai Y, Shimizu H, et al. Mycoplasma pneumoniae pneumonia in the elderly. Med Sci Monit. 2008;14(8):Cr387\u201391.","journal-title":"Med Sci Monit"},{"issue":"3","key":"11811_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF01591354","volume":"15","author":"R Bohte","year":"1996","unstructured":"Bohte R, Hermans J, van den Broek PJ. Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. 1996;15(3):201\u20135.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"11811_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2342-9-7","volume":"9","author":"N Miyashita","year":"2009","unstructured":"Miyashita N, Sugiu T, Kawai Y, Oda K, Yamaguchi T, Ouchi K, et al. Radiographic features of Mycoplasma pneumoniaepneumonia: differential diagnosis and performance timing. BMC Med Imaging. 2009;9(1):7.","journal-title":"BMC Med Imaging"},{"issue":"24","key":"11811_CR28","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.2169\/internalmedicine.51.7326","volume":"51","author":"A Haroon","year":"2012","unstructured":"Haroon A, Higa F, Fujita J, Watanabe A, Aoki N, Niki Y, et al. Pulmonary computed tomography findings in 39 cases of Streptococcus pneumoniae pneumonia. Intern Med. 2012;51(24):3343\u20139.","journal-title":"Intern Med"},{"issue":"4","key":"11811_CR29","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/archinte.1993.00410040054008","volume":"153","author":"TJ Marrie","year":"1993","unstructured":"Marrie TJ. Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch Intern Med. 1993;153(4):488\u201394.","journal-title":"Arch Intern Med"},{"issue":"2","key":"11811_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw071","volume":"3","author":"MH Diaz","year":"2016","unstructured":"Diaz MH, Cross KE, Benitez AJ, Hicks LA, Kutty P, Bramley AM, et al. Identification of bacterial and viral codetections with Mycoplasma pneumoniae using the TaqMan array card in patients hospitalized with community-acquired pneumonia. Open Forum Infect Dis. 2016;3(2):ofw071.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"11811_CR31","doi-asserted-by":"publisher","first-page":"e1001444","DOI":"10.1371\/journal.pmed.1001444","volume":"10","author":"EB Spuesens","year":"2013","unstructured":"Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Adrichem LN, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444.","journal-title":"PLoS Med"}],"updated-by":[{"DOI":"10.1186\/s12879-025-12014-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000}}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11811-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11811-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11811-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T06:35:46Z","timestamp":1762583746000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11811-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11811"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11811-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12879-025-12014-x","URL":"https:\/\/doi.org\/10.1186\/s12879-025-12014-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Lund Regional Ethics Committee (Nos. 2016\/220 and 2016\/340) and performed in adherence with the Declaration of Helsinki. Written informed consent was signed by participants or next of kin prior to inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JA and KR are participating in projects supported by Pfizer. KR has been collaborating with Moderna and has been a scientific advisor and lecturer for GSK, MSD and Pfizer. JA has received payments for lectures and\/or participated in advisory boards for AstraZeneca and GSK, MSD, MEDA, and Pfizer. AN has received payments for lectures from Mediahuset, for expert testimony from IQVIA and Securis, and for participating in Data Safety Monitoring Boards (DSMB) or Advisory Boards from Astra Zeneca, Pfizer, and Jansen Pharmaceuticals. All outside of the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1292"}}